Index -
P/E -
EPS (ttm) -0.48
Insider Own 0.01%
Shs Outstand 1.12B
Perf Week 2.62%
Market Cap 15.82B
Forward P/E 5.35
EPS next Y 2.64
Insider Trans -85.80%
Shs Float 1.12B
Perf Month 7.79%
Income -527.00M
PEG -
EPS next Q 0.52
Inst Own 52.47%
Short Float 0.93%
Perf Quarter 34.00%
Sales 15.84B
P/S 1.00
EPS this Y -6.11%
Inst Trans 9.55%
Short Ratio 0.96
Perf Half Y 40.96%
Book/sh 6.70
P/B 2.11
EPS next Y 9.71%
ROA -1.20%
Short Interest 10.46M
Perf Year 61.07%
Cash/sh 2.88
P/C 4.90
EPS next 5Y 1.60%
ROE -6.84%
52W Range 7.09 - 14.45
Perf YTD 35.15%
Dividend Est. -
P/FCF 6.82
EPS past 5Y 26.63%
ROI -2.03%
52W High -2.35%
Beta 1.05
Dividend TTM -
Quick Ratio 0.69
Sales past 5Y -2.68%
Gross Margin 48.24%
52W Low 99.15%
ATR (14) 0.33
Dividend Ex-Date Nov 27, 2017
Current Ratio 1.02
EPS Y/Y TTM 77.75%
Oper. Margin 20.15%
RSI (14) 64.54
Volatility 2.23% 2.43%
Employees 37226
Debt/Eq 2.70
Sales Y/Y TTM 6.11%
Profit Margin -3.33%
Recom 2.00
Target Price 15.75
Option/Short Yes / Yes
LT Debt/Eq 2.46
EPS Q/Q 136.88%
Payout -
Rel Volume 0.94
Prev Close 14.43
Sales Surprise 10.69%
EPS Surprise 30.29%
Sales Q/Q 13.62%
Earnings Jan 31 BMO
Avg Volume 10.90M
Price 14.11
SMA20 3.62%
SMA50 9.74%
SMA200 38.67%
Trades
Volume 10,246,622
Change -2.22%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-08-24 Upgrade
JP Morgan
Underweight → Neutral
$14
Feb-12-24 Upgrade
Piper Sandler
Neutral → Overweight
$12 → $19
Jan-23-24 Upgrade
Jefferies
Hold → Buy
$10 → $14
Jan-03-24 Upgrade
Piper Sandler
Underweight → Neutral
$8 → $12
Dec-18-23 Initiated
HSBC Securities
Buy
$13
Nov-27-23 Upgrade
UBS
Neutral → Buy
$11 → $13
Jul-06-23 Upgrade
UBS
Sell → Neutral
$7 → $8
May-25-23 Initiated
Morgan Stanley
Equal-Weight
$10
May-18-23 Upgrade
Evercore ISI
In-line → Outperform
Jan-19-23 Downgrade
Jefferies
Buy → Hold
$10 → $12
Nov-14-22 Downgrade
JP Morgan
Neutral → Underweight
$11 → $10
Nov-04-22 Downgrade
UBS
Neutral → Sell
Oct-21-22 Resumed
Jefferies
Buy
$10
Aug-05-22 Upgrade
BofA Securities
Neutral → Buy
$10 → $13
Jun-14-22 Resumed
UBS
Neutral
$10
May-17-22 Upgrade
BofA Securities
Underperform → Neutral
$9
May-04-22 Downgrade
Piper Sandler
Neutral → Underweight
$11 → $7
Apr-05-22 Upgrade
Barclays
Equal Weight → Overweight
$11 → $13
Mar-25-22 Upgrade
Bernstein
Mkt Perform → Outperform
$11
Jan-27-22 Downgrade
Argus
Buy → Hold
Show Previous Ratings
Mar-24-24 07:30PM
Mar-21-24 11:10PM
(Thomson Reuters StreetEvents)
Mar-18-24 03:06PM
(The Wall Street Journal)
Mar-08-24 05:00AM
Feb-26-24 02:19PM
09:58AM
Loading…
09:58AM
07:00AM
Feb-23-24 08:15PM
Feb-20-24 08:30AM
04:43AM
04:00AM
Feb-16-24 09:04AM
08:57AM
(Thomson Reuters StreetEvents)
Feb-13-24 12:08AM
Feb-12-24 10:18AM
(Yahoo Finance Video) +7.49%
05:02PM
Loading…
Feb-09-24 05:02PM
Feb-05-24 09:02AM
Feb-01-24 11:42AM
Jan-31-24 04:05PM
(Investor's Business Daily)
03:51PM
02:55PM
01:30PM
01:07PM
10:30AM
10:20AM
09:09AM
(Investor's Business Daily)
08:10AM
07:52AM
07:20AM
07:00AM
06:32AM
Loading…
06:32AM
06:20AM
06:00AM
Jan-28-24 12:42PM
Jan-26-24 09:15AM
Jan-25-24 09:40AM
Jan-23-24 01:43AM
Jan-12-24 09:00AM
(Investor's Business Daily)
Jan-10-24 05:21AM
Jan-02-24 04:30PM
Dec-29-23 06:43PM
06:34PM
06:14PM
Dec-28-23 04:30PM
Dec-26-23 10:51AM
Dec-22-23 10:54AM
Dec-21-23 05:45AM
Dec-15-23 05:21AM
Dec-14-23 08:30AM
Dec-07-23 02:03PM
Dec-06-23 02:00AM
Nov-30-23 08:30AM
Nov-27-23 10:14AM
09:56AM
09:37AM
08:15AM
01:50AM
Nov-24-23 08:16PM
Nov-20-23 04:30PM
Nov-17-23 08:30AM
Nov-15-23 07:03PM
Nov-13-23 08:10AM
08:00AM
Nov-12-23 12:02AM
Nov-09-23 01:21PM
Nov-08-23 04:31PM
04:01PM
(Investor's Business Daily)
03:05PM
02:15PM
01:22PM
12:05PM
(Investor's Business Daily)
09:30AM
09:01AM
(Investor's Business Daily)
08:04AM
07:40AM
07:37AM
07:27AM
07:00AM
Nov-07-23 04:30PM
Nov-02-23 11:23AM
08:00AM
Nov-01-23 07:31PM
Oct-30-23 04:35PM
Oct-25-23 09:00AM
Oct-18-23 04:56AM
Oct-17-23 01:30AM
Oct-10-23 12:26PM
10:52AM
Oct-06-23 05:11PM
(The Wall Street Journal)
04:30PM
Oct-04-23 07:45PM
04:08PM
(Investor's Business Daily)
10:47AM
(Investor's Business Daily)
10:37AM
01:07AM
Sep-28-23 04:05PM
Sep-26-23 04:33PM
Sep-20-23 07:34PM
Sep-13-23 05:21AM
Sep-06-23 04:30PM
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kalif Eliyahu Sharon EVP, Chief Financial Officer Mar 06 '24 Sale 13.52 77,550 1,048,119 203,691 Mar 07 04:27 PM Sabag Mark EVP, International Markets Mar 05 '24 Sale 13.52 100,000 1,352,090 382,590 Mar 07 04:12 PM Daniell Richard Exec. VP, European Commercial Mar 05 '24 Sale 13.52 48,629 657,240 69,770 Mar 07 04:20 PM Conway Vikki L See "Remarks" Mar 05 '24 Sale 13.52 1,427 19,286 15,219 Mar 07 04:16 PM Daniell Richard Exec. VP, European Commercial Mar 04 '24 Sale 13.34 95,762 1,277,207 69,770 Mar 05 04:21 PM Francis Richard D President and CEO Mar 04 '24 Sale 13.34 31,061 414,270 123,295 Mar 05 04:27 PM Hughes Eric A See "Remarks" Mar 04 '24 Sale 13.34 8,045 107,299 16,855 Mar 05 04:16 PM Conway Vikki L See "Remarks" Mar 04 '24 Sale 13.37 3,532 47,234 6,617 Mar 05 04:39 PM Daniell Richard Exec. VP, European Commercial Feb 28 '24 Sale 13.12 20,599 270,176 69,770 Mar 01 06:43 AM Drape Eric Executive VP Global Operations Feb 28 '24 Sale 13.12 9,815 128,734 9,701 Mar 01 06:45 AM Conway Vikki L See "Remarks" Feb 28 '24 Sale 13.12 1,366 17,916 2,928 Mar 01 06:40 AM Drape Eric Executive VP Global Operations Feb 16 '24 Sale 13.05 173,261 2,261,905 1 Feb 21 07:37 AM Francis Richard D President and CEO Feb 15 '24 Sale 13.15 74,530 980,174 87,125 Feb 20 07:42 AM Weiss Amir Chief Accounting Officer Feb 01 '24 Sale 12.37 31,766 392,955 10,676 Feb 05 07:49 AM Kalif Eliyahu Sharon EVP, Chief Financial Officer Aug 07 '23 Sale 9.73 35,125 341,889 99,162 Aug 09 04:02 PM Weiss Amir Chief Accounting Officer Aug 04 '23 Sale 9.92 1,981 19,658 42,442 Aug 07 04:15 PM Hughes Eric A See "Remarks" Aug 01 '23 Sale 8.30 52,742 437,690 0 Aug 03 07:09 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite